Trials / Completed
CompletedNCT03811444
Simulated Clinical Use Testing On Safety Lancets (Test B)
Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test A)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- HTL-Strefa S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A simulated clinical use testing on the HTL-Strefa's safety lancets
Detailed description
This study aims to evaluate the safety of the use of the safety lancets: Haemolance Plus, Prolance and MediSafe Solo in the prevention of NSI and to evaluate the user's opinion with regards to the handling characteristics of the medical devices. The simulated use clinical study will involve healthcare professionals (HCPs) who routinely use safety lancets to collect blood samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Haemolance Plus safety lancet | Haemolance Plus safety lancet type 420 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients |
| DEVICE | Prolance safety lancet | Prolance safety lancet type 430 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients. |
| DEVICE | MediSafe Solo safety lancet | MediSafe Solo safety lancet type 520 is a sterile, single use medical device designed for the sampling of capillary blood from the fingertip of patients. |
Timeline
- Start date
- 2018-11-30
- Primary completion
- 2018-12-13
- Completion
- 2018-12-13
- First posted
- 2019-01-22
- Last updated
- 2019-01-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03811444. Inclusion in this directory is not an endorsement.